| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNA) has 2 insiders with recent SEC Form 4 filings, including 14 buys and 6 sells. ERNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 41.66M | $325.78M | - | |
| VP | 110 | $860.20 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Cherington Charles | 10% Owner | Buy | 21,241,163 | $0.10 | $2,221,825.65 | +104.0% | -56.3% | - | |
| Apr 2, 2025 | Cherington Charles | 10% Owner | Buy | 3,768,397 | $0.10 | $394,174.33 | +22.7% | -36.5% | -93.0% | |
| Oct 29, 2024 | Cherington Charles | 10% Owner | Buy | 13,252,112 | $0.00 | - | +50.9% | -60.0% | -89.3% | |
| Dec 2, 2022 | Halpern John D | 10% Owner | Buy | 335,920 | $3.28 | $1,101,817.60 | +292.0% | +13.6% | -63.0% | |
| Dec 2, 2022 | Singer Nicholas Jason | Director | Buy | 283,286 | $3.28 | $929,178.08 | +270.4% | +13.6% | -63.0% | |
| Dec 2, 2022 | Cherington Charles | Director, 10% Owner | Buy | 261,756 | $3.28 | $858,559.68 | +88.8% | +13.6% | -63.0% | |
| Jul 14, 2021 | Denny George P III | 10% Owner | Buy | 3 | $13.48 | $40.45 | +100.0% | -24.6% | -95.0% | |
| Jul 6, 2021 | Denny George P III | 10% Owner | Sell | 75,000 | $16.06 | $1,204,687.50 | -1.5% | -43.3% | -96.0% | |
| Jun 17, 2021 | Cherington Charles | Director, 10% Owner | Sell | 400,000 | $15.74 | $6,296,567.80 | -2.2% | -20.2% | -96.8% | |
| Aug 13, 2020 | Ellin Robert S63 | 10% Owner | Sell | 327,650 | $5.55 | $1,816,968.07 | -95.2% | - | - |